A real head-turner
Survey finds half of respondents not yet ready for ELD mandate
Online poll: 49% still haven’t selected an ELD
Baby formula maker calls global recall over salmonella fears
PARIS (AP) — Baby milk maker Lactalis and French authorities have ordered a global recall of millions of products over fears of salmonella bacteria contamination.
Wake up Canada! We need to move oil across this country to tidewater – and soon!
Half unprepared for ELD mandate: Survey
Merck raises stakes in lung cancer as rivals close in
Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer. Shares of Merck have fallen 10 percent since the drugmaker several weeks ago said it would make survival a main goal of a key lung cancer trial for immunotherapy Keytruda, extending the study by up to a year. In the meantime, Roche Holding AG has shaken up Wall Street expectations for the $15-billion (£11.3 billion) lung cancer market, showing its Tecentriq immunotherapy slows the spread of advanced lung cancer when combined with older treatments.